Insider Transactions Reported by 17 Insiders of COGNITION THERAPEUTICS INC

Symbol
CGTX on Nasdaq
Location
Purchase, NY

There are no Buy or Sell transactions made by insiders since 11 Mar 2025

COGNITION THERAPEUTICS INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Aaron G.L. Fletcher Director, 10%+ Owner $14,927,227 19 Sep 2025
Ogden CAP Associates, LLC 10%+ Owner $2,320,896 13 Oct 2021
Lisa Ricciardi CEO & President, Director $1,959,652 15 Feb 2026
Leslie W. Kreis Director, 10%+ Owner $1,572,603 18 Jun 2025
BIOS Memory SPV I, LP 10%+ Owner $1,495,215 13 Oct 2021
Anthony Caggiano Chief Medical Officer $968,694 15 Feb 2026
John Brendan Doyle Chief Financial Officer $691,610 15 Feb 2026
Bios Clinical Opportunity Fund, LP Director, 10%+ Owner $525,100 08 Nov 2023
Mark H. Breedlove Director $432,653 13 Oct 2021
Peggy Wallace Director $22,479 18 Jun 2025
ELLEN B. RICHSTONE Director $15,210 18 Jun 2025
Jack A. Khattar Director $12,610 18 Jun 2025
Brett P. Monia Director $12,610 18 Jun 2025
Golden Seeds Cognition Therapeutics LLC 10%+ Owner 27 Sep 2022
Andrew J. Einhorn Interim CFO 12 Aug 2022
James Michael O'Brien Chief Financial Officer 23 Mar 2022
BP Directors, LP Affiliate of director 31 Jan 2022

Recent Insider Transactions by Companies or Individuals for COGNITION THERAPEUTICS INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.